This site does not support your browser.
We recommend you to upgrade to the latest version:
The Board of Directors of PharmaMar is chaired by José María Fernández Sousa-Faro and is responsible for deciding on the most important issues for the company, including those related to governance.
PharmaMar’s core business is oncology and it fully owns other companies that cover different aspects of healthcare and consumer chemical products.
PhamaMar´s has been awarded and recognized by several institutions and agencies because of its commitment to discovering new marine-derived compounds, to society, to biodiversity, and to its people.